[Federal Register Volume 59, Number 34 (Friday, February 18, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-3735]


[[Page Unknown]]

[Federal Register: February 18, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Workshop: Hereditary Breast, Ovarian, and Colon Cancer

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the National Cancer Institute 
(NCI) will sponsor a workshop to review the molecular genetics and 
epidemiology of hereditary cancer of the breast, ovary, and colon; to 
develop approaches to screening, early detection and chemoprevention of 
cancers in at-risk family members; and to discuss the psychosocial and 
ethical implications of genetic screening. This workshop will focus on 
approaches to the identification and study of families at risk, 
assuring quality in the development of wide-scale genetic testing, 
developing a framework for prevention/intervention studies, assessing 
the counseling needs of individuals at risk for hereditary cancer, and 
defining the evolving role of the physician in counseling patients 
concerning cancer risk.
    All sessions will be open to the public; however, limited seating 
is available, and registration will be on a first-come, first-served 
basis.

DATES: The workshop will be held on April 27-29, 1994, in Washington, 
DC.

ADDRESSES: Meeting agendas and registration materials can be obtained 
from Ms. Andrea Brooks, RII Conference Planner, suite 300, Silver 
Spring, MD 20910 (telephone: 301-650-7417) or RII's Conference 
Department (telephone: 301-565-4048; fax: 301-565-5112).

FOR FURTHER INFORMATION CONTACT:Dr. Ruthann M. Giusti, Division of 
Cancer Treatment, National Cancer Institute, Building 31, room 3A44, 
Bethesda, Maryland 20892 (telephone 301-496-6404; fax: 301-496-0826).

    Effective date: January 31, 1994.
Harold Varmus,
Director, NIH.
[FR Doc. 94-3735 Filed 2-17-94; 8:45 am]
BILLING CODE 4140-01-M